Cargando…

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Bekric, Dino, Tornesello, Maria Lina, Ocker, Matthias, Mayr, Christian, Kiesslich, Tobias, Neureiter, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656678/ https://www.ncbi.nlm.nih.gov/pubmed/38020902 http://dx.doi.org/10.3389/fcell.2023.1320084

Ejemplares similares

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review
por: Bekric, Dino, et al.
Publicado: (2020)

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
por: Bekric, Dino, et al.
Publicado: (2023)

Biliary tract cancer stem cells - translational options and challenges
por: Mayr, Christian, et al.
Publicado: (2017)

Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2023)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
por: Ocker, Matthias, et al.
Publicado: (2021)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2019)

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)

Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
por: Mayr, Christian, et al.
Publicado: (2016)

Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells
por: WACHTER, Julia, et al.
Publicado: (2011)

MicroRNAs Associated with the Efficacy of Photodynamic Therapy in Biliary Tract Cancer Cell Lines
por: Wagner, Andrej, et al.
Publicado: (2014)

The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
por: Klieser, Eckhard, et al.
Publicado: (2019)

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
por: Beyreis, Marlena, et al.
Publicado: (2019)

Editorial: Exosomes as Therapeutic Systems
por: Corradetti, Bruna, et al.
Publicado: (2021)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
por: Cerasuolo, Andrea, et al.
Publicado: (2020)

Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma
por: Cheng, Chi-Wai, et al.
Publicado: (2020)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
por: Tornesello, Maria Lina, et al.
Publicado: (2023)

Editorial: Immunological imbalance: What is its role in intervertebral disc degeneration?
por: Gantenbein, Benjamin, et al.
Publicado: (2023)

Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
por: Yang, Yanlei, et al.
Publicado: (2022)

Editorial: Extracellular Vesicles as Next Generation Therapeutics
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2022)

Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities
por: Wong, Pooi-Fong
Publicado: (2022)

Editorial: Nanomaterials for targeted delivery of therapeutic and imaging agents
por: Chockalingam, S., et al.
Publicado: (2022)

Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023)

Diagnostic, Therapeutic, and Prognostic Value of the m(6)A Writer Complex in Hepatocellular Carcinoma
por: Gu, Zongting, et al.
Publicado: (2022)

Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
por: Korkaya, Hasan, et al.
Publicado: (2020)

Editorial: Non-apoptotic cell death mechanisms and their therapeutic significance
por: Lopus, Manu, et al.
Publicado: (2022)

Editorial: Cerebellar development and medulloblastoma: new players and therapeutic options
por: Ceccarelli, Manuela
Publicado: (2023)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

The Therapeutic Potential of Adipose Tissue-Derived Mesenchymal Stem Cells to Enhance Radiotherapy Effects on Hepatocellular Carcinoma
por: Wu, Lingyun, et al.
Publicado: (2019)

Editorial: The Vascular Niche in Tissue Repair: A Therapeutic Target for Regeneration
por: Rivera, Francisco J., et al.
Publicado: (2017)

Editorial: Advances in iPSC technology for disease modeling and therapeutic applications
por: Wattanapanitch, Methichit, et al.
Publicado: (2023)

Editorial: Emerging Functions of Septins
por: Menon, Manoj B., et al.
Publicado: (2017)

Editorial: Interplay Between Autophagy and Metabolic Syndrome: Causes, Consequences and Therapeutic Challenges
por: Rodrigues, Stephen F., et al.
Publicado: (2021)

Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis
por: Bargiela, Ariadna, et al.
Publicado: (2022)

Editorial: Protein modifications in epigenetic dysfunctional diseases: mechanisms and potential therapeutic strategies
por: Ji, Jing, et al.
Publicado: (2023)

Editorial: Novel therapeutic strategies for chronic kidney disease: from bench to bedside
por: Huang, Chunling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5vqvkj5132b868qu8d1qnakpqa